Debiopharm Group™ (Debiopharm) and Spinomix SA, a Swiss company advancing molecular diagnostic technologies, announced the closing of a Series A equity investment of $ 3 Million. The financing round was led by Debiopharm Group™.
Reportlinker.com announces that a new market research report is available in its catalogue: A Magnetic Moment: Prospects for MRAM Technology, Markets and Applications
NanoViricides, Inc. (the "Company") announced today that it has retained Id3A, LLC (“Id3A”), as the architect for its laboratory and cGMP pilot production facility project. As previously announced, this facility will be built by renovating an existing 18,000 sq. ft. light manufacturing plant on a 4.2 acre lot in Shelton, CT. Ms. Kathyann Cowles, AIA, will serve as the Principal Architect for the project. Id3A recently began working with the Company for the architecture portion and now the Company has formally engaged Id3A as the architects for this project.
NanoViricides, Inc. (the "Company"), announced today that it has received the final tranche of $2.5M from Seaside 88, LP (“Seaside”), thereby completing the total of a $5M financing. This raise, and the receipt of the initial $2.5M tranche, was previously announced on June 29, 2012.
Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases, announced today that it has secured a $16 million Series B financing. Blend is pioneering an integrative model for discovering novel molecular entities with new mechanisms of action purposely designed for Blend’s proprietary nanoparticles. By synergistically developing both the molecule and the nanoparticle together, Blend can make medicines more targeted, more effective and more tolerable.
Applied DNA Sciences, Inc., (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that the UK Metropolitan Police Service (MPS) will be using its proprietary DNANet™ property marking kits as part of a major initiative to reduce crime in targeted London neighborhoods.
Thin Film Electronics ASA announced today the first proof-of-concept prototype of an integrated printed electronic tag based on rewritable memory.
ARM and Cadence Design Systems, Inc. today announced the tape-out of the first 14-nanometer test chip implementation of the high-performance ARM® Cortex™-A7 processor, the most energy-efficient applications processor from ARM.
Samsung Electronics Co., Ltd., a global leader in advanced semiconductor solutions, today announced that it reached another milestone in the development of 14-nanometer (nm) FinFET process technology with the successful tape-out of multiple development vehicles in collaboration with its key design and IP partners.
Ultratech, Inc., a leading supplier of lithography and laser-processing systems used to manufacture semiconductor devices and high-brightness LEDs (HB-LEDs), today announced that it has acquired the assets of Cambridge Nanotech, Inc. (Cambridge).
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.